The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Continuous Glucose Monitoring Devices Market Research Report 2024
Synopsis
A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
The global Continuous Glucose Monitoring Devices market was valued at US$ 4612 million in 2023 and is anticipated to reach US$ 5979.4 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
Global Continuous Glucose Monitoring Systems key players include Dexcom, Abbott Laboratories, Medtronic, etc. Global top three manufacturers hold a share about 95%.
North America is the largest market, with a share about 65%, followed by Europe and Asia-Pacific, both have a share about 30 percent.
In terms of product, Wearable is the largest segment, with a share about 99%. And in terms of application, the largest application is Adult, followed by Elderly.
This report aims to provide a comprehensive presentation of the global market for Continuous Glucose Monitoring Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Glucose Monitoring Devices.
Report Scope
The Continuous Glucose Monitoring Devices market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Continuous Glucose Monitoring Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Glucose Monitoring Devices companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Echo Therapeutics, Inc.
Dexcom, Inc.
GlySens Incorporated
Medtronic plc
Senseonics Holdings, Inc.
Johnson & Johnson
F. Hoffmann-La Roche Ltd.
AgaMatrix, Inc.
Glucovation
GlySure
Arkray USA, Inc.
OrSense
Segment by Type
Sensors
Transmitters & Receivers
Insulin Pumps
Segment by Application
Diabetic Patients
Healthy Individuals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Continuous Glucose Monitoring Devices companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
The global Continuous Glucose Monitoring Devices market was valued at US$ 4612 million in 2023 and is anticipated to reach US$ 5979.4 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
Global Continuous Glucose Monitoring Systems key players include Dexcom, Abbott Laboratories, Medtronic, etc. Global top three manufacturers hold a share about 95%.
North America is the largest market, with a share about 65%, followed by Europe and Asia-Pacific, both have a share about 30 percent.
In terms of product, Wearable is the largest segment, with a share about 99%. And in terms of application, the largest application is Adult, followed by Elderly.
This report aims to provide a comprehensive presentation of the global market for Continuous Glucose Monitoring Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Glucose Monitoring Devices.
Report Scope
The Continuous Glucose Monitoring Devices market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Continuous Glucose Monitoring Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Glucose Monitoring Devices companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Echo Therapeutics, Inc.
Dexcom, Inc.
GlySens Incorporated
Medtronic plc
Senseonics Holdings, Inc.
Johnson & Johnson
F. Hoffmann-La Roche Ltd.
AgaMatrix, Inc.
Glucovation
GlySure
Arkray USA, Inc.
OrSense
Segment by Type
Sensors
Transmitters & Receivers
Insulin Pumps
Segment by Application
Diabetic Patients
Healthy Individuals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Continuous Glucose Monitoring Devices companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Continuous Glucose Monitoring Devices Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sensors
1.2.3 Transmitters & Receivers
1.2.4 Insulin Pumps
1.3 Market by Application
1.3.1 Global Continuous Glucose Monitoring Devices Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diabetic Patients
1.3.3 Healthy Individuals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Continuous Glucose Monitoring Devices Market Perspective (2019-2030)
2.2 Continuous Glucose Monitoring Devices Growth Trends by Region
2.2.1 Global Continuous Glucose Monitoring Devices Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Continuous Glucose Monitoring Devices Historic Market Size by Region (2019-2024)
2.2.3 Continuous Glucose Monitoring Devices Forecasted Market Size by Region (2025-2030)
2.3 Continuous Glucose Monitoring Devices Market Dynamics
2.3.1 Continuous Glucose Monitoring Devices Industry Trends
2.3.2 Continuous Glucose Monitoring Devices Market Drivers
2.3.3 Continuous Glucose Monitoring Devices Market Challenges
2.3.4 Continuous Glucose Monitoring Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Continuous Glucose Monitoring Devices Players by Revenue
3.1.1 Global Top Continuous Glucose Monitoring Devices Players by Revenue (2019-2024)
3.1.2 Global Continuous Glucose Monitoring Devices Revenue Market Share by Players (2019-2024)
3.2 Global Continuous Glucose Monitoring Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Continuous Glucose Monitoring Devices Revenue
3.4 Global Continuous Glucose Monitoring Devices Market Concentration Ratio
3.4.1 Global Continuous Glucose Monitoring Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Continuous Glucose Monitoring Devices Revenue in 2023
3.5 Continuous Glucose Monitoring Devices Key Players Head office and Area Served
3.6 Key Players Continuous Glucose Monitoring Devices Product Solution and Service
3.7 Date of Enter into Continuous Glucose Monitoring Devices Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Continuous Glucose Monitoring Devices Breakdown Data by Type
4.1 Global Continuous Glucose Monitoring Devices Historic Market Size by Type (2019-2024)
4.2 Global Continuous Glucose Monitoring Devices Forecasted Market Size by Type (2025-2030)
5 Continuous Glucose Monitoring Devices Breakdown Data by Application
5.1 Global Continuous Glucose Monitoring Devices Historic Market Size by Application (2019-2024)
5.2 Global Continuous Glucose Monitoring Devices Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Continuous Glucose Monitoring Devices Market Size (2019-2030)
6.2 North America Continuous Glucose Monitoring Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Continuous Glucose Monitoring Devices Market Size by Country (2019-2024)
6.4 North America Continuous Glucose Monitoring Devices Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Continuous Glucose Monitoring Devices Market Size (2019-2030)
7.2 Europe Continuous Glucose Monitoring Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Continuous Glucose Monitoring Devices Market Size by Country (2019-2024)
7.4 Europe Continuous Glucose Monitoring Devices Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Continuous Glucose Monitoring Devices Market Size (2019-2030)
8.2 Asia-Pacific Continuous Glucose Monitoring Devices Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Continuous Glucose Monitoring Devices Market Size by Region (2019-2024)
8.4 Asia-Pacific Continuous Glucose Monitoring Devices Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Continuous Glucose Monitoring Devices Market Size (2019-2030)
9.2 Latin America Continuous Glucose Monitoring Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Continuous Glucose Monitoring Devices Market Size by Country (2019-2024)
9.4 Latin America Continuous Glucose Monitoring Devices Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Continuous Glucose Monitoring Devices Market Size (2019-2030)
10.2 Middle East & Africa Continuous Glucose Monitoring Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Continuous Glucose Monitoring Devices Market Size by Country (2019-2024)
10.4 Middle East & Africa Continuous Glucose Monitoring Devices Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Continuous Glucose Monitoring Devices Introduction
11.1.4 Abbott Laboratories Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Echo Therapeutics, Inc.
11.2.1 Echo Therapeutics, Inc. Company Detail
11.2.2 Echo Therapeutics, Inc. Business Overview
11.2.3 Echo Therapeutics, Inc. Continuous Glucose Monitoring Devices Introduction
11.2.4 Echo Therapeutics, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.2.5 Echo Therapeutics, Inc. Recent Development
11.3 Dexcom, Inc.
11.3.1 Dexcom, Inc. Company Detail
11.3.2 Dexcom, Inc. Business Overview
11.3.3 Dexcom, Inc. Continuous Glucose Monitoring Devices Introduction
11.3.4 Dexcom, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.3.5 Dexcom, Inc. Recent Development
11.4 GlySens Incorporated
11.4.1 GlySens Incorporated Company Detail
11.4.2 GlySens Incorporated Business Overview
11.4.3 GlySens Incorporated Continuous Glucose Monitoring Devices Introduction
11.4.4 GlySens Incorporated Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.4.5 GlySens Incorporated Recent Development
11.5 Medtronic plc
11.5.1 Medtronic plc Company Detail
11.5.2 Medtronic plc Business Overview
11.5.3 Medtronic plc Continuous Glucose Monitoring Devices Introduction
11.5.4 Medtronic plc Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.5.5 Medtronic plc Recent Development
11.6 Senseonics Holdings, Inc.
11.6.1 Senseonics Holdings, Inc. Company Detail
11.6.2 Senseonics Holdings, Inc. Business Overview
11.6.3 Senseonics Holdings, Inc. Continuous Glucose Monitoring Devices Introduction
11.6.4 Senseonics Holdings, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.6.5 Senseonics Holdings, Inc. Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Continuous Glucose Monitoring Devices Introduction
11.7.4 Johnson & Johnson Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.7.5 Johnson & Johnson Recent Development
11.8 F. Hoffmann-La Roche Ltd.
11.8.1 F. Hoffmann-La Roche Ltd. Company Detail
11.8.2 F. Hoffmann-La Roche Ltd. Business Overview
11.8.3 F. Hoffmann-La Roche Ltd. Continuous Glucose Monitoring Devices Introduction
11.8.4 F. Hoffmann-La Roche Ltd. Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.8.5 F. Hoffmann-La Roche Ltd. Recent Development
11.9 AgaMatrix, Inc.
11.9.1 AgaMatrix, Inc. Company Detail
11.9.2 AgaMatrix, Inc. Business Overview
11.9.3 AgaMatrix, Inc. Continuous Glucose Monitoring Devices Introduction
11.9.4 AgaMatrix, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.9.5 AgaMatrix, Inc. Recent Development
11.10 Glucovation
11.10.1 Glucovation Company Detail
11.10.2 Glucovation Business Overview
11.10.3 Glucovation Continuous Glucose Monitoring Devices Introduction
11.10.4 Glucovation Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.10.5 Glucovation Recent Development
11.11 GlySure
11.11.1 GlySure Company Detail
11.11.2 GlySure Business Overview
11.11.3 GlySure Continuous Glucose Monitoring Devices Introduction
11.11.4 GlySure Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.11.5 GlySure Recent Development
11.12 Arkray USA, Inc.
11.12.1 Arkray USA, Inc. Company Detail
11.12.2 Arkray USA, Inc. Business Overview
11.12.3 Arkray USA, Inc. Continuous Glucose Monitoring Devices Introduction
11.12.4 Arkray USA, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.12.5 Arkray USA, Inc. Recent Development
11.13 OrSense
11.13.1 OrSense Company Detail
11.13.2 OrSense Business Overview
11.13.3 OrSense Continuous Glucose Monitoring Devices Introduction
11.13.4 OrSense Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.13.5 OrSense Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
